|
Time
|
Title
|
Speaker
|
Moderators
|
|
12:30 pm – 1:00 pm
|
Registration
|
Secretariat
|
|
|
1:00 pm – 1: 30 pm
|
Opening Remarks
Cases for discussion
|
Dr. Hassan Al Thani
Chair, Surgical Endocrine Symposium
Head of Trauma and Vascular Surgery
|
|
|
Introduction
Objective: To provide information about the structures, roles and function of the pancreas and signs and symptoms of neuroendocrine tumors.
|
|
1:30 pm – 1:50 pm
|
Anatomy & Physiology of the Pancreas
|
Dr. Saif Al Mudares
Resident, General Surgery
|
Dr. Maryam Al Sulaiti
Dr. Abdelhakim Tabeb
|
|
1:50 pm -2:10 pm
|
Clinical Presentation of Pancreas NeuroEndocrine Tumors
|
Dr. Hassan Al Thani
Chair, Surgical Endocrine Symposium
Head of Trauma and Vascular Surgery
|
|
Genetics/ Pathology
Objective: To have a thorough understanding of the genetics, pathology and classification of neuroendocrine tumors which is essential in accurately assessing and treating patients with neuroendocrine abnormalities.
|
|
2:10 pm – 2:30 pm
|
Genetics of Sporadic and Familial Pancreas NeuroEndocrine Tumors
|
Dr. Maryam Al Sulaiti
Senior Consultant, General Surgery
|
|
|
2:30 pm – 3:00 pm
|
Pancreatic NeuroEndocrine Tumors Pathological Classification
|
Dr. Mahir Petkar
Senior Consultant Pathologist
|
|
|
3:00 pm - 3:20 pm
|
Asr Prayer
Coffee Break
|
|
Imaging
Objective: To recognize the importance of pancreatic imaging which is an essential tool in the early diagnosis and staging of pancreatic neuroendocrine tumors.
|
|
3:20 pm – 3:40 pm
|
Role of CT in Pancreatic NeuroEndocrine Tumors
|
Dr. Ahmed Al-Muzrakchi
Senior Consultant, Radiology Department
|
Dr. Gamila El Mabrok
Dr. Hesham El Gohary
|
|
3:40 pm – 4:00 pm
|
Role of MRI in patients with Pancreatic NeuroEndocrine Tumors
|
Dr. Ahmed Mahfouz
Senior Consultant, Radiology Department
|
|
|
4:00 pm – 4:20 pm
|
Diagnostic Imaging Using Radioactive Tracers in Pancreatic NeuroEndocrine Tumors
|
Dr. Ahmed Tarek Khairy
Senior Consultant, Radiology Department
|
|
Treatment
Objective: To prepare in providing medical management and quality care to patients with neuroendocrine tumors and related pancreatic disorders.
|
|
4:20 pm – 4:40 pm
|
Medical management of neuroendocrine tumors of the pancreas (pNETs)
|
Dr. Mohsen Eledrisi
Senior Consultant, General Medicine
|
|
|
4:40 pm – 5:00 pm
|
Management of Hyperinsulinemic Hypoglycemia Bariatric Surgery for Morbid Obesity
|
Dr. Moataz Bashah
Senior Consultant, Head of Bariatric Surgery
|
|
|
5:00 pm – 5:20 pm
|
The exocrine and endocrine pancreas after acute pancreatitis; are we neglecting an important disease?
|
Dr. Shaikh Nissaruddin Maheboob
Senior Consultant, Anaesthesia
|
|
|
5:20 pm - 5:40 pm
|
Pancreatic islet cell transplantation Approaches to Treating Type 1 Diabetes
|
Dr. Shaimaa Ahmad Arroub
Clinical Fellow, Endocrinology, Medical Education
|
|
|
5: 40pm – 6:00 pm
|
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review
|
Dr. Maryam Al Sulaiti
Senior Consultant, General Surgery
|
|
|
6:00 pm - 6:30 pm
|
Maghrib Prayer
Coffee Break
|
|
|
6:30 pm – 6:50 pm
|
Open Surgical resection of neuroendocrine tumors of the pancreas (pNETs) is the first choice?
|
Dr. Mohamed Said Hassan Ghali
Associate Consultant, General Surgery
|
Dr. Hassan Al Thani
Dr. Maryam Al Sulaiti
Dr. Abdelhakim Tabeb
|
|
6:50 pm – 7:10 pm
|
Laparoscopic Surgical resection of neuroendocrine tumors of the pancreas (pNETs) is the first choice?
|
Dr. Ahmed Elaffandi
Senior Consultant, General Surgery
|
|
7:10 pm – 7:30 pm
|
Laparoscopic versus Open Pancreas Resection for Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-analysis
|
Dr. Abdelhakim Tabeb
Senior Consultant, General Surgery
|
|
7:30 pm – 7:50 pm
|
When Is Liver Resection Indicated in Metastatic Pancreatic Neuroendocrine Tumors and What is the Role of Liver Transplantation
|
Dr. Ibnouf Sulieman
Clinical Fellow, Endocrinology, Medical Education
|
|
7:50 pm – 8:10 pm
|
Non-surgical Treatments for Pancreatic Neuroendocrine Tumors Chemotherapy/ Target Therapy & others
|
Dr. Kakil Ibrahim Rasul Senior Consultant, National Center for Cancer Care and Research
|
|
8:10 pm – 8:30 pm
|
Appendicular Neuroendocrine Tumors (NET, Carcinoid tumors)
|
Dr. Abdulrahman Abdel Aal
Consultant, General Surgery
|
|
8:30 pm – 8:50 pm
|
Consensus Guidelines for the Management of Functional p‐ NETs (F‐p‐NETs) and non‐functional p‐NETs (NF‐p‐NETs)
|
Dr. Hassan Al Thani
Chair, Surgical Endocrine Symposium, Head of Trauma and Vascular Surgery
|
|
8:50 pm – 9:00pm
|
Closing Remarks
|
Dr. Hassan Al Thani
Chair, Surgical Endocrine Symposium, Head of Trauma and Vascular Surgery
|
|
